AR

Akhilesh Rai

Active Director Director DIN 07906317
DIN 07906317 First appointment Aug 2017 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2017
Shareholding value •••• Premium profile

About Akhilesh Rai

Data last updated:

Akhilesh Rai is a Director at Ssbell Pharmaceuticals Private Limited (since 2017). The company operates in Chemicals. Ssbell Pharmaceuticals Private Limited reported revenue of ₹30,020 (FY 2025).

DIN 07906317
Primary Designation Director
Industry Chemicals
First Appointment 21 Aug 2017
Oldest Company Age 9 yrs
Largest company Ssbell Pharmaceuticals Private Limited · ₹30,020 (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director21 Aug 20172017₹30,020 (FY 2025)Active

Board colleagues of Akhilesh Rai

Directorship timeline

Open interactive timeline →
Ssbell Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Akhilesh Rai

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Akhilesh Rai

Akhilesh Rai currently holds 1 directorship: Ssbell Pharmaceuticals Private Limited (Director, since 21 Aug 2017, revenue ₹30,020 (FY 2025)).

Akhilesh Rai was first appointed on 21 Aug 2017 as Director at Ssbell Pharmaceuticals Private Limited.

The current boards of Akhilesh Rai's companies include Lokesh Rai (Ssbell Pharmaceuticals Private Limited), Satish Singh (Ssbell Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available